ADVFN Logo
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Hipay Group Sa

Hipay Group Sa (0RA7)

15.25
0.00
( 0.00% )
Updated: 19:00:00

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
15.25
Bid
0.00
Ask
0.00
Volume
0.00
0.00 Day's Range 0.00
15.25 52 Week Range 15.25
Market Cap
Previous Close
15.25
Open
-
Last Trade
(O)
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
1
Shares Outstanding
4,961,000
Dividend Yield
-
PE Ratio
11.54
Earnings Per Share (EPS)
0.44
Revenue
66.45M
Net Profit
2.17M

About Hipay Group Sa

Sector
Finance Services
Industry
Finance Services
Website
Headquarters
Levallois-perret, Hauts-de-seine, Fra
Founded
-
Hipay Group Sa is listed in the Finance Services sector of the London Stock Exchange with ticker 0RA7. The last closing price for Hipay was 15.25 €. Over the last year, Hipay shares have traded in a share price range of 15.25 € to 15.25 €.

Hipay currently has 4,961,000 shares outstanding. The market capitalization of Hipay is 75.66 € million. Hipay has a price to earnings ratio (PE ratio) of 11.54.

0RA7 Latest News

HiPay Group: HiPay continues its growth with a 9% increase in revenues in 2022

HiPay Group: HiPay continues its growth with a 9% increase in revenues in 2022 HiPay Group In a continuous growth momentum, annual revenues have risen 9% compared to 2021, and 29% compared to...

HiPay Group : Communiqué du Conseil d’Administration de HiPay Group SA

HiPay Group : Communiqué du Conseil d’Administration de HiPay Group SA Paris, le 28 octobre 2022 : Le Conseil d’Administration de HiPay Group SA (code ISIN FR0012821916 – ALHYP), la fintech...

HiPay Group:

HiPay Group: HiPay Group   HiPay regains growth momentum with 16% increase in Q3 revenue   Quarterly payment volume of 1.7 billion euros, an 18% increase compared to the third quarter of 2021...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10015.2515.2515.25415.25DE
40015.2515.2515.25115.25DE
120015.2515.2515.25115.25DE
260015.2515.2515.25015.25DE
520015.2515.2515.25115.25DE
1560015.2515.2515.254315.25DE
2600015.2515.2515.255915.25DE

0RA7 - Frequently Asked Questions (FAQ)

What is the current Hipay share price?
The current share price of Hipay is 15.25 €
How many Hipay shares are in issue?
Hipay has 4,961,000 shares in issue
What is the market cap of Hipay?
The market capitalisation of Hipay is EUR 75.66M
What is the 1 year trading range for Hipay share price?
Hipay has traded in the range of 15.25 € to 15.25 € during the past year
What is the PE ratio of Hipay?
The price to earnings ratio of Hipay is 11.54
What is the cash to sales ratio of Hipay?
The cash to sales ratio of Hipay is 0.38
What is the reporting currency for Hipay?
Hipay reports financial results in EUR
What is the latest annual turnover for Hipay?
The latest annual turnover of Hipay is EUR 66.45M
What is the latest annual profit for Hipay?
The latest annual profit of Hipay is EUR 2.17M
What is the registered address of Hipay?
The registered address for Hipay is 94, RUE DE VILLIERS, LEVALLOIS-PERRET, HAUTS-DE-SEINE, 92300
What is the Hipay website address?
The website address for Hipay is hipay.com/fr/
Which industry sector does Hipay operate in?
Hipay operates in the FINANCE SERVICES sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TM1Technology Minerals Plc
0.15p
(25.00%)
11.48M
MASTMast Energy Developments Plc
0.205p
(17.14%)
7.65M
OMIOrosur Mining Inc
8.25p
(17.02%)
180.01k
NFXNuformix Plc
0.07p
(16.67%)
15.44M
ZIOCZanaga Iron Ore Company Limited
8.66p
(9.76%)
22.07k
VRSVersarien Plc
0.03p
(-16.67%)
134.87k
THSTharisa Plc
55.50p
(-14.62%)
44.18k
EYEEagle Eye Solutions Group Plc
405.00p
(-14.01%)
9.29k
ZENZenith Energy Ltd.
5.50p
(-10.57%)
245.98k
4GBL4global Plc
45.50p
(-9.00%)
95
TRPTower Resources Plc
0.0405p
(2.53%)
95.59M
CPXCap-xx Limited
0.155p
(-4.62%)
32.99M
DGIDg Innovate Plc
0.0185p
(-7.50%)
23.47M
NFXNuformix Plc
0.07p
(16.67%)
15.44M
ORCPOracle Power Plc
0.019p
(0.00%)
13.53M

Discussion

View Full Feed
Hi_Lo Hi_Lo 1 minute ago
Lol!! I want profits!! What you want helps me in no way!!
Exactly. Because the truth with documentation that BCAP is a scam and Jake P. Noch is a serial scammer prevents pumping liars like you from making profits. And that's part of my goal - and to help people know the facts about this scam
BCAP
DiamondHealer95 DiamondHealer95 5 minutes ago
What do you expect and how can you back your thoughts? Thanks
KBLB
DiamondHealer95 DiamondHealer95 11 minutes ago
I mean Kim said once they hit 1.5 metric tons they're open for business and they're about halfway there so..... You're a genius! Congrats on the business. I also run one with 100% positive feedback over 22 years so I get the perspective🤪

Also, in my Arby's voice "I have the
KBLB
DiamondHealer95 DiamondHealer95 14 minutes ago
We've invested similarly
KBLB
sunspotter sunspotter 25 minutes ago
Glenn Miller’s still missing, and Emil Malak and Rich Inza are still crooks.
VPLM
Flobewan Flobewan 36 minutes ago
Marc loved your ides
tinojax tinojax 37 minutes ago
I usually enjoy a beer with my pizza...........I would like to know what's in the Kool Aid........
PLUG
mrfence mrfence 40 minutes ago
Here we are on the cusp of the Monsta $FMCC~ $FNMA~ Gains we've all been waiting for doin da Heebie Jeebie Dance, 😃😄😁😆😅😂!
[yt]MUB3ZR4F8vw?si=Z3oB5zc_RHMtCGEY[/yt]
FMCC FNMA
IVRT IVRT 56 minutes ago
In my opinion, there will likely be significant pressure on the share price leading up to the conference call. A sell-off could occur the day before, with the stock potentially bottoming out by the end of the investor call. I could be wrong, but I've seen similar patterns many times over the past 25
BMXI
DewDiligence DewDiligence 56 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

ENTA
DewDiligence DewDiligence 57 minutes ago
GSK acquires—(private)—IDRx for $1B up-front + $150M contingency:

https://www.businesswire.com/news/home/20250112698434/en • Acquisition includes IDRX-42, a highly selective KIT tyrosine kinase inhibitor (TKI) designed to treat gastrointestinal stromal tumours (GIST)

Guido2 Guido2 58 minutes ago
This is DUE DILIGENCE! Thank you Free Fannie.

https://x.com/freefannie/status/1878655047715991552?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ
FNMA
StockItOut StockItOut 1 hour ago
That Xeriant PR excellently written with bullshit:

""After successfully completing 75% of the demanding NFPA 286 test," meaning = "after failing the NFPA 286 test by missing 25% of the approval target testing requirement,"

"the Company used the data to make several key
XERI
gitreal gitreal 1 hour ago
You were actually partially right....BMXI has filed some SEC documents, some necessary (Form 1-A), some unnecessary (Form 4). And they do summarize a lot of the stuff that I think are fabrications....their production, mining operations, etc. Time will tell, but I think a lot of it (and probably
BMXI
RichieBoy RichieBoy 1 hour ago
Jim wrote a blurb about seeking more US business.

Help you out any? 🤨
AFFU
DesktopDR DesktopDR 1 hour ago
Any news or updates?
VPLM
Tahoe2468 Tahoe2468 1 hour ago
.0915 by Thursday....... 
KRTL
skitahoe skitahoe 1 hour ago
Remember GBM was redefined during the trial, thus some who were treated then had other forms of brain cancer. I believe the least we'll see in our label is brain cancer. Certainly GBM may be the deadliest of them, but treatment should work in all of them.

According to Google, GBM ha
NWBO
fuagf fuagf 1 hour ago
You are right about the crafty, evil, smart. Authoritarian methods have been in full view
in capturing America. While we work to do the right things they plot to capture the lot.
facts_matter14 facts_matter14 1 hour ago
If there weren’t suckers born every minute, there wouldn’t be POSRMX bag holders down as much as 99%, and there sure as hell wouldn’t be anybody believing there is a pipeline of products.






.
SRMX
StockItOut StockItOut 1 hour ago
Your "closer" keeps getting extended. Then again extended. Then again extended. -- Consider that end. Now expired, horizon end now reached, and the view clarifies and we see it to be your desperation from years ago ongoing still, to pump this at any expense, where you attempt to instill FOMO to hold
XERI
fuagf fuagf 1 hour ago
He would smother any question with words.

Your Recent History

Delayed Upgrade Clock